Company Search:
Advanced Search
Sponsored Links
Aileron Therapeutics Inc Company Snapshot
Aileron Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aileron Therapeutics Inc with three other companies in this sector in the United States: Luna Innovations Incorporated (2013 sales of $22.05 million of which 52% was Technology Development), Bioanalytical Systems, Inc. ($22.07 million of which 75% was Services), and Silex Systems Ltd ($20.68 million of which 113% was Silex Systems).

Sales Analysis.
  Stock Performance Chart for Aileron Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): .43
(Figures in U.S. Dollars)
1 Week -12.7%   13 Weeks -54.9%  
4 Weeks -33.0%   52 Weeks -82.6%  
Aileron Therapeutics Inc Key Data:
  Ticker: ALRN Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2013 Sales 22,350,000
(Year Ending Jan 2014).
Employees: 23
  Currency: U.S. Dollars Market Cap: 12,041,885
  Fiscal Yr Ends: December Shares Outstanding: 27,810,358
  Share Type: Common Closely Held Shares: 11,360,062
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.